Christopher Eberhardt
Christopher Eberhardt

Christopher Eberhardt

Partner

London

+44 20 7859 2712 | +44 7824 747 379
Christopher.Eberhardt@ashurstperkins.com

Introduction

Christopher is a partner in the antitrust and competition practice and handles high-value merger clearances, competition investigations, and consumer protection matters across the UK and EU.

Christopher Eberhardt is admitted to practice in both England & Wales and Ireland. He has extensive experience advising clients in a wide range of sectors before the UK Competition and Markets Authority, sectoral regulators in the UK (including Ofcom and the FCA), and the UK Competition Appeal Tribunal, as well as before the European Commission and European Courts.

Christopher advises clients on all aspects of UK and EU competition law. Christopher regularly manages merger control and FDI or UK national security clearances for high value, complex and multi-jurisdictional mergers. His behavioral practice covers contentious and non-contentious matters, regularly advising a wide range of clients on competition and market investigations, and competition compliance. 

Christopher also practices UK consumer protection law and has experience advising clients on consumer law compliance and enforcement. He is co-editor of the ICLG Consumer Protection Guide. 

  • A large global investment bank in relation to an investigation by the CMA under the Competition Act in relation to alleged collusive manipulation of financial (bond) markets.
  • A Tier 1 civil engineering firm in relation to the CMA's market study into the design, planning and delivery of railway and public road infrastructure by the civil engineering sector in the UK.
  • A leading UK insurer in connection with new consumer protection obligations introduced by the Digital Markets, Competition and Consumers Act 2024.
  • A global financial data and analytics provider in relation to the FCA's wholesale data market study which examined benchmarks, credit ratings data and market data vendors.
  • IHS Markit in relation to its $44 billion merger with S&P Global.
  • Royal Mail in relation to Ofcom's investigation into to an alleged abused of dominance in relation to the pricing of bulk mail delivery services in the UK, its appeal to the Competition Appeal Tribunal of Ofcom's infringement decision, and the subsequent appeal to the Court of Appeal.
  • Babcock in relation to the sale of part of its helicopter services business, which was subject to a CMA Phase 2 investigation.
  • Circle Health in relation to its acquisition of BMI Healthcare which created the UK's leading private hospital operator and was cleared at Phase 1 by the CMA, subject to the divestment of 2 hospitals in Bath and Birmingham, and in relation to is successful application to vary the UILs accepted by the CMA.
  • Markit in connection with the European Commission's investigation under Article 101 TFEU into allegations of collusive conduct in the market for credit default swaps.

Latest thinking

Carousel: clicking the "Previous" or "Next" button changes the content between the buttons.

Latest news, deals and awards

Carousel: clicking the "Previous" or "Next" button changes the content between the buttons.